Table 1 Demographic characteristics and clinical data
From: The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
Variables | Patients (n = 1321) | Patients with peritonitis (n = 372) | Patients free of peritonitis (n = 949) | P value |
|---|---|---|---|---|
Age (years) | 48.1 ± 15.3 | 51.1 ± 14.7 | 46.9 ± 15.4 | <0.001 |
Sex (Male, n, %) | 776 (58.7%) | 220 (59.1%) | 556 (58.6%) | 0.86 |
Primary renal disease (n, %) | - | - | - | 0.006 |
 Glomerulonephritis | 776 (58.7%) | 199 (53.5%) | 577 (60.8%) | - |
 Diabetic nephropathy | 298 (22.6%) | 84 (22.6%) | 214 (22.6%) | - |
 Hypertension | 91 (6.9%) | 38 (10.2%) | 53 (5.6%) | - |
 Others | 156 (11.8%) | 51 (13.7%) | 105 (11.1%) | - |
Diabetes mellitus (n, %) | 311 (23.5%) | 87 (23.4%) | 224 (23.6%) | 0.93 |
History of CVD (n, %) | 479 (36.3%) | 139 (37.4%) | 340 (35.8%) | 0.62 |
Duration of PD (months) | 34 (21–48) | 40 (26–56) | 32 (18–46) | <0.001 |
24-h urine output (mL) | 900 (500–1300) | 875 (500–1300) | 900 (500–1300) | 0.53 |
Hemoglobin (g/dL) | 9.4 ± 2.3 | 9.2 ± 2.3 | 9.4 ± 2.3 | 0.133 |
Serum phosphorus (mg/dL) | 5.2 ± 1.7 | 5.1 ± 1.7 | 5.2 ± 1.8 | 0.124 |
Serum albumin (g/dL) | 3.6 ± 0.5 | 3.6 ± 0.5 | 3.7 ± 0.5 | 0.080 |